0
0.5
1
1.5
2+
Viral clearance
92%
Improvement
Relative Risk
Recovery
77%
Recovery time
85%
no CI
Recovery time (b)
81%
no CI
Proxalutamide Cadegiani et al. EARLY TREATMENT DB RCT
Is early treatment with antiandrogens beneficial for COVID-19?
Double-blind RCT 237 patients in Brazil
Improved viral clearance (p<0.0001) and recovery (p<0.0001)
c19early.org
Cadegiani et al., Cureus, February 2021
Favors proxalutamide
Favors control